| Product Name | 4-Hydroxycarbazole |
|---|---|
| Synonyms / Abbreviations | 4-Hydroxy-9H-carbazole, 4-Carbazolol, 9H-Carbazol-4-ol |
| CAS Number | 52602-39-8 |
| Molecular Formula | C12H9NO |
| Molecular Weight | 183.21 g/mol |
| Appearance | White to Light Brown Powder |
| Purity (HPLC) | ≥ 99.0% |
| Melting Point | 165°C - 168°C |
This heterocyclic compound is the pivotal intermediate for synthesizing Carvedilol, a non-selective beta-blocker/alpha-1 blocker used to treat mild to severe congestive heart failure and high blood pressure.
Detailed quality specifications, compliance data, and procurement answers for pharma sourcing professionals.
| Chemical Synonyms | 4-Hydroxy-9H-carbazole, 4-Carbazolol, 9H-Carbazol-4-ol, Carvedilol intermediate |
|---|---|
| Manufacturing Location | Kalpasthana Life Care Products, Plot no 105, Part A, KIADB Industrial Area, Humnabad, Bidar District, Karnataka, India - 585330 |
| Compliance & Quality | GMP-compliant state-of-the-art facility, rigorous HPLC purity standards ≥99.0%. |
| Commercial Packaging | Standard 25 kg HDPE fiber drums with double polythene inner bags; custom B2B packaging available. |
4-Hydroxycarbazole (also known as 4-Carbazolol or 9H-Carbazol-4-ol) is the direct precursor to Carvedilol, a widely prescribed beta-blocker. The carbazole ring and the hydroxyl group at the 4-position undergo highly selective epoxidation, making it the most cost-effective and chemically stable starting point for this API synthesis.
Kalpasthana ensures a high purity profile for 4-Hydroxycarbazole of ≥99.0% by HPLC. We strictly monitor critical impurities like 2-hydroxycarbazole and other positional isomers to ensure the safety and efficacy of the final API. Full technical packages (MSDS, COA, DMF support) are available for B2B audits.
The compound is packed in 25 kg HDPE fiber drums with double poly-bags. Since it is sensitive to oxidation and light, it must be stored in tightly closed, light-resistant containers. We maintain ready bulk stocks to support long-term supply contracts for global pharmaceutical companies.